Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00884871 · ClinicalTrials.gov registry record

Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders

A clinical trial of Pelvic Floor Disorders, sponsored by University of California, San Diego.

Completed
Registry status
100
Enrollment target
1
Study location

NCT00884871: Completed study of Pelvic Floor Disorders, sponsored by University of California, San Diego.

NCT00884871 is a study of Pelvic Floor Disorders that has completed, run by University of California, San Diego. The registered enrollment target is 100 participants, roughly in line with the 107-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00884871, a study of Pelvic Floor Disorders, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in severely, morbidly and super-obese women using a prospective, observational study design.

Conditions Studied

Interventions

  • PROCEDURE LapBand

Study Locations (1)

California

  • University of California San Diego Medical Center - La Jolla

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2007-09
Est. Completion 2009-11
University of California, San Diego

775 total trials

What the finished NCT00884871 record still lists

NCT00884871 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 107-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target.

The record links to 1 condition, with Pelvic Floor Disorders appearing as the primary indexed condition, and to 1 intervention - of which LapBand is the first listed.

NCT00884871 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00884871 about?

NCT00884871 is a clinical study titled "Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders". The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in sever...

What is the current status of trial NCT00884871?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2007-09. Estimated completion is 2009-11.

What conditions does trial NCT00884871 study?

This clinical trial studies the following conditions: Pelvic Floor Disorders.

What interventions are being tested in trial NCT00884871?

The interventions under investigation include: LapBand (PROCEDURE).

Who is sponsoring clinical trial NCT00884871?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00884871 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Floor Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00884871's enrollment target sits among peer trials

100 6th of 11 higher than 6 of 11 other Pelvic Floor Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pelvic Floor Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00884871, the US trial registry maintained by the National Library of Medicine. NCT00884871 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.